Connection
Brian Sauer to Veterans
This is a "connection" page, showing publications Brian Sauer has written about Veterans.
|
|
Connection Strength |
|
 |
|
 |
|
4.475 |
|
|
|
-
Patel S, Pinnell D, Qualls J, Rathod A, Chen W, Boutin S, Woods SD, Kovesdy CP, Tangri N, Sauer BC. Assessing patiromer utilization and associated serum potassium changes in US veterans with prior sodium polystyrene sulfonate exposure. Medicine (Baltimore). 2023 Mar 03; 102(9):e33134.
Score: 0.393
-
Pinnell D, Patel S, Qualls J, Chen W, Rathod A, Woods SD, Boutin S, Kovesdy CP, Tangri N, Sauer BC. Real-world evaluation of patiromer utilization and its effects on serum potassium in veterans with end stage kidney disease. Medicine (Baltimore). 2022 Dec 16; 101(50):e32367.
Score: 0.388
-
Sauer BC, Chen W, Xu Y, Shen J, Accortt NA, Collier DH, Cannon GW. Empirical evidence of disease activity thresholds used to indicate need for major therapeutic change in US veterans with rheumatoid arthritis. Arthritis Res Ther. 2020 10 22; 22(1):253.
Score: 0.334
-
Halwani AS, Rasmussen KM, Patil V, Morreall D, Li C, Yong C, Burningham Z, Dawson K, Masaquel A, Henderson K, DeLong-Sieg E, Sauer BC. Maintenance rituximab in Veterans with follicular lymphoma. Cancer Med. 2020 10; 9(20):7537-7547.
Score: 0.330
-
Stever JR, Cannon GW, Teng CC, Accortt NA, Collier DH, Sauer BC. Utility of administrative and clinical data to predict major change in medical treatment in US Veterans enrolled in the Veterans Affairs Rheumatoid Arthritis (VARA) registry. Clin Exp Rheumatol. 2019 Jul-Aug; 37(4):552-560.
Score: 0.292
-
Walsh JA, Pei S, Burningham Z, Penmetsa G, Cannon GW, Clegg DO, Sauer BC. Use of Disease-modifying Antirheumatic Drugs for Inflammatory Arthritis in US Veterans: Effect of Specialty Care and Geographic Distance. J Rheumatol. 2018 03; 45(3):430-436.
Score: 0.272
-
Walsh JA, Shao Y, Leng J, He T, Teng CC, Redd D, Treitler Zeng Q, Burningham Z, Clegg DO, Sauer BC. Identifying Axial Spondyloarthritis in Electronic Medical Records of US Veterans. Arthritis Care Res (Hoboken). 2017 09; 69(9):1414-1420.
Score: 0.267
-
Sauer BC, Teng CC, Accortt NA, Burningham Z, Collier D, Trivedi M, Cannon GW. Models solely using claims-based administrative data are poor predictors of rheumatoid arthritis disease activity. Arthritis Res Ther. 2017 05 08; 19(1):86.
Score: 0.263
-
Sauer BC, Teng CC, He T, Leng J, Lu CC, Walsh JA, Shah N, Harrison DJ, Tang DH, Cannon GW. Treatment patterns and annual biologic costs in US veterans with rheumatic conditions or psoriasis. J Med Econ. 2016; 19(1):34-43.
Score: 0.235
-
Walsh JA, Zhou X, Clegg DO, Teng C, Cannon GW, Sauer B. Mortality in American Veterans with the HLA-B27 gene. J Rheumatol. 2015 Apr; 42(4):638-44.
Score: 0.225
-
Cannon GW, DuVall SL, Haroldsen CL, Caplan L, Curtis JR, Michaud K, Mikuls TR, Reimold A, Collier DH, Harrison DJ, Joseph GJ, Sauer BC. Persistence and dose escalation of tumor necrosis factor inhibitors in US veterans with rheumatoid arthritis. J Rheumatol. 2014 Oct; 41(10):1935-43.
Score: 0.217
-
Johnson TM, Yang Y, Roul P, Sauer BC, Cannon GW, Kunkel G, Michaud K, Baker JF, Mikuls TR, England BR. A Narrowing Mortality Gap: Temporal Trends of Cause-Specific Mortality in a National Matched Cohort Study in US Veterans With Rheumatoid Arthritis. Arthritis Care Res (Hoboken). 2023 08; 75(8):1648-1658.
Score: 0.098
-
Wheeler AM, Roul P, Yang Y, Brittan KM, Sayles H, Singh N, Sauer BC, Cannon GW, Baker JF, Mikuls TR, England BR. Risk of Prostate Cancer in US Veterans With Rheumatoid Arthritis. Arthritis Care Res (Hoboken). 2023 04; 75(4):785-792.
Score: 0.096
-
Natalini JG, England BR, Baker JF, Chen Q, Singh N, Mahajan TD, Roul P, Thiele GM, Sauer BC, Mikuls TR, Johnson FB, Kawut SM. Associations between shortened telomeres and rheumatoid arthritis-associated interstitial lung disease among U.S. Veterans. Respir Med. 2022 09; 201:106943.
Score: 0.094
-
Passey D, Healy R, Qualls J, Hamilton CJ, Tilley E, Burningham Z, Sauer B, Halwani A. Development and implementation of a pharmacist-led telehealth medication management program for veterans receiving oral antineoplastic therapies through the MISSION Act. Am J Health Syst Pharm. 2022 05 24; 79(11):835-843.
Score: 0.093
-
Natalini JG, Baker JF, Singh N, Mahajan TD, Roul P, Thiele GM, Sauer BC, Johnson CR, Kawut SM, Mikuls TR, England BR. Autoantibody Seropositivity and Risk for Interstitial Lung Disease in a Prospective Male-Predominant Rheumatoid Arthritis Cohort of U.S. Veterans. Ann Am Thorac Soc. 2021 04; 18(4):598-605.
Score: 0.086
-
Li C, Patil V, Rasmussen KM, Yong C, Chien HC, Morreall D, Humpherys J, Sauer BC, Burningham Z, Halwani AS. Predicting Survival in Veterans with Follicular Lymphoma Using Structured Electronic Health Record Information and Machine Learning. Int J Environ Res Public Health. 2021 03 07; 18(5).
Score: 0.086
-
Chien HC, Morreall D, Patil V, Rasmussen KM, Yong CM, Li CY, Passey DG, Burningham Z, Sauer BC, Halwani AS. Real-world treatment patterns and outcomes in a national study of veterans with Waldenstr?m macroglobulinemia, 2006-2019. Am J Hematol. 2021 06 01; 96(6):E184-E187.
Score: 0.085
-
Halwani AS, Rasmussen KM, Patil V, Li CC, Yong CM, Burningham Z, Gupta S, Narayanan S, Lin SW, Carroll S, Mhatre SK, Graff JN, Dreicer R, Sauer BC. Real-world practice patterns in veterans with metastatic castration-resistant prostate cancer. Urol Oncol. 2020 01; 38(1):1.e1-1.e10.
Score: 0.078
-
Burningham Z, Chen W, Sauer BC, Richter Lagha R, Hansen J, Huynh T, Patel S, Leng J, Halwani A, Kramer BJ. VA Geriatric Scholars Program's impact on prescribing potentially inappropriate medications. Am J Manag Care. 2019 09; 25(9):425-430.
Score: 0.077
-
England BR, Sayles H, Michaud K, Thiele GM, Poole JA, Caplan L, Sauer BC, Cannon GW, Reimold A, Kerr GS, Baker JF, Mikuls TR. Chronic lung disease in U.S. Veterans with rheumatoid arthritis and the impact on survival. Clin Rheumatol. 2018 Nov; 37(11):2907-2915.
Score: 0.072
-
Bress AP, Dodson JA, King JB, Sauer BC, Reese T, Crook J, Radwanski P, Knippenberg K, Greene T, Nelson RE, Munger MA, Weintraub WS, LaFleur J. Clinical and Economic Outcomes of Ranolazine Versus Conventional Antianginals Users Among Veterans With Chronic Stable Angina Pectoris. Am J Cardiol. 2018 12 01; 122(11):1809-1816.
Score: 0.072
-
Jones BE, Haroldsen C, Madaras-Kelly K, Goetz MB, Ying J, Sauer B, Jones MM, Leecaster M, Greene T, Fridkin SK, Neuhauser MM, Samore MH. In Data We Trust? Comparison of Electronic Versus Manual Abstraction of Antimicrobial Prescribing Quality Metrics for Hospitalized Veterans With Pneumonia. Med Care. 2018 07; 56(7):626-633.
Score: 0.071
-
Cannon GW, DuVall SL, Haroldsen CL, Caplan L, Curtis JR, Michaud K, Mikuls TR, Reimold A, Collier DH, Joseph GJ, Harrison DJ, Sauer BC. Clinical Outcomes and Biologic Costs of Switching Between Tumor Necrosis Factor Inhibitors in US Veterans with Rheumatoid Arthritis. Adv Ther. 2016 08; 33(8):1347-59.
Score: 0.062
-
Nelson RE, Nebeker JR, Sauer BC, LaFleur J. Factors associated with screening or treatment initiation among male United States veterans at risk for osteoporosis fracture. Bone. 2012 Apr; 50(4):983-8.
Score: 0.045
-
Rupper RW, Bair BD, Sauer BC, Nebeker JR, Shinogle J, Samore M. Out-of-pocket pharmacy expenditures for veterans under medicare part D. Med Care. 2007 Oct; 45(10 Supl 2):S77-80.
Score: 0.034
-
England BR, Campany M, Sayles H, Roul P, Yang Y, Ganti AK, Sokolove J, Robinson WH, Reimold AM, Kerr GS, Cannon GW, Sauer BC, Baker JF, Thiele GM, Mikuls TR. Associations of serum cytokines and chemokines with the risk of incident cancer in a prospective rheumatoid arthritis cohort. Int Immunopharmacol. 2021 Aug; 97:107719.
Score: 0.022
-
Chien HC, Morreall D, Patil V, Rasmussen KM, Li C, Yong CM, Burningham Z, Masaquel A, Halloran M, De Long-Sieg E, Schulz M, Sauer BC, Halwani AS. Real-world practice patterns and outcomes in Veterans with relapsed/refractory diffuse large B-cell lymphoma. Future Oncol. 2021 Feb; 17(4):411-422.
Score: 0.021
-
Walsh JA, Pei S, Penmetsa GK, Sauer BC, Patil V, Walker JH, Clewell J, Douglas KM, Clegg DO, Cannon GW, Halwani A. Treatment Patterns with Disease-Modifying Antirheumatic Drugs in U.S. Veterans with Newly Diagnosed Rheumatoid Arthritis, Psoriatic Arthritis, or Ankylosing Spondylitis. J Manag Care Spec Pharm. 2019 Nov; 25(11):1218-1228.
Score: 0.020
-
Cheng Y, Sauer B, Zhang Y, Nickman NA, Jamjian C, Stevens V, LaFleur J. Adherence and virologic outcomes among treatment-na?ve veteran patients with human immunodeficiency virus type 1 infection. Medicine (Baltimore). 2018 Jan; 97(2):e9430.
Score: 0.017
-
Cheng Y, Nickman NA, Jamjian C, Stevens V, Zhang Y, Sauer B, LaFleur J. Predicting poor adherence to antiretroviral therapy among treatment-na?ve veterans infected with human immunodeficiency virus. Medicine (Baltimore). 2018 Jan; 97(2):e9495.
Score: 0.017
-
LaFleur J, Nelson RE, Sauer BC, Nebeker JR. Overestimation of the effects of adherence on outcomes: a case study in healthy user bias and hypertension. Heart. 2011 Nov; 97(22):1862-9.
Score: 0.011
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|